(Q40163305)

18 September 2017

title

Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment (English)

1 reference

18 September 2017

1 reference

Shuchi Mittal

1

1 reference

18 September 2017

Deepti Dubey

series ordinal

2

1 reference

18 September 2017

Kazuhiro Yamakawa

series ordinal

3

1 reference

18 September 2017

Subramaniam Ganesh

series ordinal

4

1 reference

18 September 2017

publication date

2 March 2007

1 reference

18 September 2017

published in

Human Molecular Genetics

1 reference

18 September 2017

volume

16

1 reference

18 September 2017

issue

7

1 reference

18 September 2017

page(s)

753-762

1 reference

Advances in the genetics of progressive myoclonus epilepsy

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

LAFORA'S DISEASE. DISTINCT CLINICO-PATHOLOGIC FORM OF UNVERRICHT'S SYNDROME.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Mutations in NHLRC1 cause progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

The role of ubiquitin-protein ligases in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

The aggravating role of the ubiquitin-proteasome system in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Ubiquitin-protein ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Lewy-body formation is an aggresome-related process: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Ubiquitin-proteasome system and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Parkin accumulation in aggresomes due to proteasome impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Parkin is recruited to the centrosome in response to inhibition of proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Aggresomes: a cellular response to misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Aggresomes, inclusion bodies and protein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Hassles with taking out the garbage: aggravating aggresomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Pericentrin, a highly conserved centrosome protein involved in microtubule organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Dynamic association of proteasomal machinery with the centrosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

γ-Tubulin is a highly conserved component of the centrosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Cytoplasmic dynein/dynactin mediates the assembly of aggresomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

A novel action of histone deacetylase inhibitors in a protein aggresome disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Hsp70 and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Dimerization of Laforin is required for its optimal phosphatase activity, regulation of GSK3beta phosphorylation, and Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

A chloroplast-localized dual-specificity protein phosphatase in Arabidopsis contains a phylogenetically dispersed and ancient carbohydrate-binding domain, which binds the polysaccharide starch

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Biochemical studies on tissues from a patient with lafora disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

Glycogen metabolism in tissues from a mouse model of Lafora disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDM006

21 January 2018

Identifiers

DOI

10.1093/HMG/DDM006

1 reference

18 September 2017

1 reference